US Bancorp DE trimmed its position in shares of Centene Corporation (NYSE:CNC – Free Report) by 28.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 307,194 shares of the company’s stock after selling 124,447 shares during the period. US Bancorp DE owned approximately 0.06% of Centene worth $10,961,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Addison Advisors LLC increased its holdings in Centene by 455.6% in the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after purchasing an additional 606 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC bought a new position in shares of Centene during the third quarter valued at $27,000. WPG Advisers LLC raised its position in Centene by 44.5% during the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after purchasing an additional 282 shares during the last quarter. Bogart Wealth LLC raised its position in shares of Centene by 11,011.1% during the third quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after acquiring an additional 991 shares during the last quarter. Finally, Financial Network Wealth Advisors LLC increased its position in shares of Centene by 54.9% during the third quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock worth $39,000 after buying an additional 390 shares during the period. 93.63% of the stock is owned by institutional investors.
Centene Price Performance
CNC stock opened at $44.82 on Friday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.10 and a current ratio of 1.10. Centene Corporation has a 52-week low of $25.08 and a 52-week high of $66.03. The firm has a market capitalization of $22.04 billion, a price-to-earnings ratio of -3.29, a PEG ratio of 1.00 and a beta of 0.48. The firm has a 50 day moving average price of $42.83 and a 200-day moving average price of $37.56.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on the company. Truist Financial raised their target price on Centene from $47.00 to $49.00 and gave the stock a “buy” rating in a research note on Wednesday. TD Cowen raised their price objective on Centene from $34.00 to $38.00 and gave the company a “hold” rating in a research note on Wednesday, February 11th. Wall Street Zen cut shares of Centene from a “buy” rating to a “hold” rating in a research report on Sunday, February 15th. Weiss Ratings restated a “sell (d)” rating on shares of Centene in a report on Wednesday, January 21st. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $41.00 target price on shares of Centene in a research note on Monday, February 9th. Three research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $42.00.
Check Out Our Latest Analysis on CNC
Centene Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Read More
- Five stocks we like better than Centene
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
